These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 23358711)
1. Urinary microRNA profiling in the nephropathy of type 1 diabetes. Argyropoulos C; Wang K; McClarty S; Huang D; Bernardo J; Ellis D; Orchard T; Galas D; Johnson J PLoS One; 2013; 8(1):e54662. PubMed ID: 23358711 [TBL] [Abstract][Full Text] [Related]
2. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes. Monteiro MB; Thieme K; Santos-Bezerra DP; Queiroz MS; Woronik V; Passarelli M; Machado UF; Giannella-Neto D; Oliveira-Souza M; Corrêa-Giannella ML Metabolism; 2016 Jun; 65(6):816-24. PubMed ID: 27173460 [TBL] [Abstract][Full Text] [Related]
3. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes. Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120 [TBL] [Abstract][Full Text] [Related]
4. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis. Eissa S; Matboli M; Bekhet MM Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555 [TBL] [Abstract][Full Text] [Related]
5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
6. Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis. Park S; Moon S; Lee K; Park IB; Lee DH; Nam S Cell Physiol Biochem; 2018; 46(4):1331-1340. PubMed ID: 29689545 [TBL] [Abstract][Full Text] [Related]
7. Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. Argyropoulos C; Wang K; Bernardo J; Ellis D; Orchard T; Galas D; Johnson JP J Clin Med; 2015 Jul; 4(7):1498-517. PubMed ID: 26239688 [TBL] [Abstract][Full Text] [Related]
9. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774 [TBL] [Abstract][Full Text] [Related]
10. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes. Ghai V; Wu X; Bheda-Malge A; Argyropoulos CP; Bernardo JF; Orchard T; Galas D; Wang K Kidney Int Rep; 2018 May; 3(3):555-572. PubMed ID: 29854963 [TBL] [Abstract][Full Text] [Related]
12. Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes. Monteiro MB; Santos-Bezerra DP; Thieme K; Admoni SN; Perez RV; Machado CG; Queiroz MS; Nery M; Oliveira-Souza M; Woronik V; Passarelli M; Giannella-Neto D; Machado UF; Corrêa-Giannella ML Free Radic Res; 2016; 50(1):101-10. PubMed ID: 26480949 [TBL] [Abstract][Full Text] [Related]
13. Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats. Mohan A; Singh RS; Kumari M; Garg D; Upadhyay A; Ecelbarger CM; Tripathy S; Tiwari S PLoS One; 2016; 11(4):e0154055. PubMed ID: 27101382 [TBL] [Abstract][Full Text] [Related]
14. Urinary exosomal microRNAs in incipient diabetic nephropathy. Barutta F; Tricarico M; Corbelli A; Annaratone L; Pinach S; Grimaldi S; Bruno G; Cimino D; Taverna D; Deregibus MC; Rastaldi MP; Perin PC; Gruden G PLoS One; 2013; 8(11):e73798. PubMed ID: 24223694 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline. Wanic K; Krolewski B; Ju W; Placha G; Niewczas MA; Walker W; Warram JH; Kretzler M; Krolewski AS PLoS One; 2013; 8(3):e57751. PubMed ID: 23505438 [TBL] [Abstract][Full Text] [Related]
16. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. El-Samahy MH; Adly AA; Elhenawy YI; Ismail EA; Pessar SA; Mowafy ME; Saad MS; Mohammed HH J Diabetes Complications; 2018 Feb; 32(2):185-192. PubMed ID: 29175120 [TBL] [Abstract][Full Text] [Related]
17. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy. An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014 [TBL] [Abstract][Full Text] [Related]
18. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy. Li W; Yang S; Qiao R; Zhang J Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042 [TBL] [Abstract][Full Text] [Related]
19. Assessment of Urinary MicroRNAs by Quantitative Polymerase Chain Reaction in Diabetic Nephropathy Patients. Newbury LJ; Wonnacott A; Simpson K; Bowen T; Fraser D Methods Mol Biol; 2020; 2067():277-285. PubMed ID: 31701457 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin. Tayel SI; Saleh AA; El-Hefnawy SM; Elzorkany KM; Elgarawany GE; Noreldin RI Curr Mol Med; 2020; 20(5):361-371. PubMed ID: 31629394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]